SCHEMBL3367668

SCHEMBL3367668

COc1[c]cccc1CN

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.37
PNMT P11086 2/20 0.34
IDO1 P14902 2/20 0.33
KEAP1 Q14145 1/20 0.33
DPP4 P27487 2/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
PDCD1LG2 Q9BQ51 1/20 0.31
CD274 Q9NZQ7 1/20 0.31
HTR2B P41595 1/20 0.31
AOC3 Q16853 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3363963 0.85 TAAR1 (0.52) TAAR1
SCHEMBL4073818 0.83 TAAR1 (0.35) TAAR1IDO1AOC3
SCHEMBL455800 0.82 GABRA1 (0.37) TAAR1IDO1MAPT
SCHEMBL2441393 0.80 PDE4A (0.35) MAPTCD274
SCHEMBL6504160 0.78 HMGCR (0.35) TAAR1GAA
SCHEMBL4090309 0.77 SLC6A4 (0.44) ALDH1A1
SCHEMBL4087791 0.77 POLB (0.40) ALDH1A1GAAMAPT
SCHEMBL11838516 0.76 ALDH1A1 (0.39) ALDH1A1HTR2B
SCHEMBL1012043 0.76 ALOX5 (0.42)
SCHEMBL8939750 0.76 LTA4H (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105658630-A Tetrazolinone compound and use thereof 住友化学株式会社 2016-06-08 CN disclosed
US-8436006-B2 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) JANSSSEN PHARMACEUTICA N.V. (BE) 2013-05-07 US disclosed
US-8426429-B2 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) JANSSSEN PHARMACEUTICA N.V. (BE) 2013-04-23 US disclosed
US-8383637-B2 2-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE) JANSSSEN PHARMACEUTICA N.V. (BE) 2013-02-26 US disclosed
EP-1776349-B1 2-AMINO-QUINAZOLINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) JANSSEN PHARMACEUTICA NV (BE) 2010-10-06 EP disclosed
CN-101387829-A Radiation-sensitive resin composition SUMITOMO CHEMICAL CO (JP) 2009-03-18 CN disclosed
US-20060178383-A1 Novel 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (BACE) JANSSEN PHARMACEUTICA, N.V. (BE) 2006-08-10 US disclosed
US-20060079687-A1 Novel 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (BACE) JANSSEN PHARMACEUTICA, N.V. (BE) 2006-04-13 US disclosed
CN-1251991-A Carboxylic acid derivatives, their preparation and their use in cancer therapy BASF AG (DE) 2000-05-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060178383-A1 Novel 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (BACE) BACE2, BACE1, APP TAAR1 3533/4885PNMT 787/4885IDO1 1338/4885
US-20060079687-A1 Novel 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (BACE) BACE2, BACE1, APP TAAR1 3533/4885PNMT 787/4885IDO1 1338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.